(Q22252794)

6 February 2023

Vera Marisa Costa

3

Vera Marisa

Costa

1 reference

6 February 2023

Helena Carmo

2

Helena

Carmo

1 reference

6 February 2023

Fernando Remião

6

Fernando

Remião

1 reference

1004296183

6 February 2023

Maria de Lourdes Bastos

object named as

Maria de Lourdes Bastos

series ordinal

8

author given names

Maria de Lourdes

author last names

Bastos

1 reference

6 February 2023

Félix Carvalho

7

Félix

Carvalho

1 reference

6 February 2023

Márcia Carvalho

1

Márcia

Carvalho

1 reference

1004296183

6 February 2023

Helena Pontes

series ordinal

5

author given names

Helena

author last names

Pontes

1 reference

1004296183

https://scigraph.springernature.com/pub.10.1007/s00204-012-0815-5

6 February 2023

language of work or name

English

0 references

publication date

6 March 2012

0 references

published in

Archives of Toxicology

0 references

volume

86

0 references

page(s)

1167-1231

0 references

issue

8

0 references

exact match

0 references

cites work

Ephedra in perspective--a current review

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Toxicological and histopathological analysis of a patient who died nine days after a single intravenous dose of methamphetamine: a case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Adderall induced inverted-Takotsubo cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Ecstasy-induced oxidative stress to adolescent rat brain mitochondria in vivo: influence of monoamine oxidase type A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Ecstasy: a common cause of severe acute hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Interactions between recreational drugs and antiretroviral agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

MDMA (ecstasy) effects on cultured serotonergic neurons: evidence for Ca2(+)-dependent toxicity linked to release.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Metabolism of N,N-dialkylated amphetamines, including deprenyl, by CYP2D6 expressed in a human cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Changes in cardiovascular responsiveness and cardiotoxicity elicited during binge administration of Ecstasy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Ambient temperature effects on 3,4-methylenedioxymethamphetamine-induced thermodysregulation and pharmacokinetics in male monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Effects of ambient temperature on the relative reinforcing strength of MDMA using a choice procedure in monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Pro-oxidant effects of Ecstasy and its metabolites in mouse brain synaptosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Acute myocardial infarction resulting from amphetamine abuse: a spasm-thrombus interplay?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Muscle changes in the neuroleptic malignant syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Ethanol-MDMA interactions in rats: the importance of interval between repeated treatments in biobehavioral tolerance and sensitization to the combination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

The substituted amphetamines 3,4-methylenedioxymethamphetamine, methamphetamine, p-chloroamphetamine and fenfluramine induce 5-hydroxytryptamine release via a common mechanism blocked by fluoxetine and cocaine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Effects of MDMA, MDA and MDEA on blood pressure, heart rate, locomotor activity and body temperature in the rat involve alpha-adrenoceptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Biochemical and toxicological properties of the oxidation products of catecholamines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Necrotizing renal vasculopathy resulting in chronic renal failure after ingestion of methamphetamine and 3,4-methylenedioxymethamphetamine ('ecstasy')

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

5-hydroxytryptamine(2A) receptors regulate sympathetic nerves constricting the cutaneous vascular bed in rabbits and rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Role of quinones in toxicology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

High doses of methamphetamine that cause disruption of the blood-brain barrier in limbic regions produce extensive neuronal degeneration in mouse hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

High dose pimozide does not block amphetamine-induced euphoria in normal volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Alcohol Use and Risk Taking Among Regular Ecstasy Users

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Coronary artery rupture associated with amphetamine abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Effects of amphetamines on mitochondrial function: role of free radicals and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

A single methamphetamine administration rapidly decreases vesicular dopamine uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Methamphetamine-induced inhibition of mitochondrial complex II: roles of glutamate and peroxynitrite

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Clinical pharmacokinetics of non-opiate abused drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Ecstasy-induced brain death and acute hepatocellular failure: multiorgan donor and liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Molecular bases of methamphetamine-induced neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

CuZn-superoxide dismutase (CuZnSOD) transgenic mice show resistance to the lethal effects of methylenedioxyamphetamine (MDA) and of methylenedioxymethamphetamine (MDMA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Metabolism of [14C]methamphetamine in man, the guinea pig and the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Association of caffeine to MDMA does not increase antinociception but potentiates adverse effects of this recreational drug.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Neurotoxicity of Ecstasy metabolites in rat cortical neurons, and influence of hyperthermia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Ecstasy-induced cell death in cortical neuronal cultures is serotonin 2A-receptor-dependent and potentiated under hyperthermia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Ecstasy induces apoptosis via 5-HT(2A)-receptor stimulation in cortical neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Neurotoxicity mechanisms of thioether ecstasy metabolites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

5,7-Dihydroxitryptamine toxicity to serotonergic neurons in serum free raphe cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Molecular and cellular mechanisms of ecstasy-induced neurotoxicity: an overview.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Influence of CYP2D6 polymorphism on 3,4-methylenedioxymethamphetamine ('Ecstasy') cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

CYP2D6 increases toxicity of the designer drug 4-methylthioamphetamine (4-MTA)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

d-Amphetamine-induced hepatotoxicity: possible contribution of catecholamines and hyperthermia to the effect studied in isolated rat hepatocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Is hyperthermia the triggering factor for hepatotoxicity induced by 3,4-methylenedioxymethamphetamine (ecstasy)? An in vitro study using freshly isolated mouse hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Effect of 3,4-methylenedioxymethamphetamine ("ecstasy") on body temperature and liver antioxidant status in mice: influence of ambient temperature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Role of metabolites in MDMA (ecstasy)-induced nephrotoxicity: an in vitro study using rat and human renal proximal tubular cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Hepatotoxicity of 3,4-methylenedioxyamphetamine and alpha-methyldopamine in isolated rat hepatocytes: formation of glutathione conjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

The toxicity of N-methyl-alpha-methyldopamine to freshly isolated rat hepatocytes is prevented by ascorbic acid and N-acetylcysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Metabolism is required for the expression of ecstasy-induced cardiotoxicity in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Mechanisms underlying the hepatotoxic effects of ecstasy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Attenuation of MDMA-induced hyperthermia by ethanol in rats depends on ambient temperature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Cardiac oxidative stress determination and myocardial morphology after a single ecstasy (MDMA) administration in a rat model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Psychoactive substrates stimulate dopamine transporter phosphorylation and down-regulation by cocaine-sensitive and protein kinase C-dependent mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Ischemic stroke after using over the counter products containing ephedra

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Analysis of association of clinical correlates and 5-HTTLPR polymorphism with suicidal behavior among Chinese methamphetamine abusers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Metabolism of drugs of abuse by cytochromes P450.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

MDMA ("ecstasy"), methamphetamine and their combination: long-term changes in social interaction and neurochemistry in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Intravenous methamphetamine self-administration in rats: effects of intravenous or intraperitoneal MDMA co-administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

MDMA, methamphetamine and their combination: possible lessons for party drug users from recent preclinical research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

In vivo evidence for free radical involvement in the degeneration of rat brain 5-HT following administration of MDMA ('ecstasy') and p-chloroamphetamine but not the degeneration following fenfluramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

In vivo evidence against clomethiazole being neuroprotective against MDMA ('ecstasy')-induced degeneration of rat brain 5-HT nerve terminals by a free radical scavenging mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Altered states: the clinical effects of Ecstasy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Ecstasy and the concomitant use of pharmaceuticals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Adrenaline and reactive oxygen species elicit proteome and energetic metabolism modifications in freshly isolated rat cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Contribution of catecholamine reactive intermediates and oxidative stress to the pathologic features of heart diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Reduced cortical gray matter density in human MDMA (Ecstasy) users: a voxel-based morphometry study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Carrier-dependent and Ca(2+)-dependent 5-HT and dopamine release induced by (+)-amphetamine, 3,4-methylendioxymethamphetamine, p-chloroamphetamine and (+)-fenfluramine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

A review of the clinical pharmacology of methamphetamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Ecstasy-induced rhabdomyolysis and its role in the development of acute renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Hyperthermia following MDMA administration in rats: effects of ambient temperature, water consumption, and chronic dosing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Contribution of cannabis and MDMA ("ecstasy") to cognitive changes in long-term polydrug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Fatality due to combined use of the designer drugs MDMA and PMA: a distribution study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Effect of adolescent exposure to MDMA and cocaine on acquisition and reinstatement of morphine-induce CPP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Non-linear pharmacokinetics of MDMA ('ecstasy') in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Pharmacology of MDMA in Humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Clinical pharmacokinetics of amfetamine and related substances: monitoring in conventional and non-conventional matrices

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Human pharmacology of MDMA: pharmacokinetics, metabolism, and disposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

MDMA (ecstasy) pharmacokinetics in a CYP2D6 poor metaboliser and in nine CYP2D6 extensive metabolisers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Distribution study of 3,4-methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine in a fatal overdose

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Interpretation of a 3,4-methylenedioxymethamphetamine (MDMA) blood level: discussion by means of a distribution study in two fatalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Amphetamines as potential inducers of fatalities: a review in the district of Ghent from 1976-2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Glutathione metabolism and its role in hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Sustained effects of ecstasy on the human brain: a prospective neuroimaging study in novel users

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Drug use and risk behaviour among regular ecstasy users: Does sexuality make a difference?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Methamphetamine causes widespread apoptosis in the mouse brain: evidence from using an improved TUNEL histochemical method

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Antagonism of cocaine, amphetamine, and methamphetamine toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Potentiation of cocaine and d-amphetamine toxicity with caffeine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Further evidence of association between amphetamine response and SLC6A2 gene variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

The role of monoamines in the changes in body temperature induced by 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and its derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

The effect of chronic renal failure on hepatic drug metabolism and drug disposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Strenuous exercise aggravates MDMA-induced skeletal muscle damage in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Mechanism of kainate toxicity to cerebellar neurons in vitro is analogous to reperfusion tissue injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Ecstasy induced hepatitis mimicking viral hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Synthesis, in vitro formation, and behavioural effects of glutathione regioisomers of alpha-methyldopamine with relevance to MDA and MDMA (ecstasy).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Acute liver damage and ecstasy ingestion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Long-Term Changes in Dopaminergic Innervation of Caudate Nucleus After Continuous Amphetamine Administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

A comparative study on the acute and long-term effects of MDMA and 3,4-dihydroxymethamphetamine (HHMA) on brain monoamine levels after i.p. or striatal administration in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Short allele of 5-HTTLPR as a risk factor for the development of psychosis in Japanese methamphetamine abusers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Acute renal failure after ecstasy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Repeated doses administration of MDMA in humans: pharmacological effects and pharmacokinetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Causes and effects of cellular oxidative stress as a result of MDMA abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Chronic ecstasy (3,4-methylenedioxymetamphetamine) abuse: a recurrent and unpredictable cause of severe acute hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Mechanism of vasopressin-induced platelet aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Quinone electrophiles selectively adduct "electrophile binding motifs" within cytochrome c.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Stereoselective pharmacokinetics of 3,4-methylenedioxymethamphetamine in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Increased flux of free radicals in cells subjected to hyperthermia: detection by electron paramagnetic resonance spin trapping

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

An association study of the brain-derived neurotrophic factor Val66Met polymorphism and amphetamine response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Impact of psychostimulants on vesicular monoamine transporter function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Pre-exposure to (+/-)3,4-methylenedioxy-methamphetamine (MDMA) facilitates acquisition of intravenous cocaine self-administration in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Regional extracellular norepinephrine responses to amphetamine and cocaine and effects of clonidine pretreatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

PET studies of d-methamphetamine pharmacokinetics in primates: comparison with l-methamphetamine and ( --)-cocaine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Fast uptake and long-lasting binding of methamphetamine in the human brain: comparison with cocaine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Thermoregulatory effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Effects of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy') and para-methoxyamphetamine on striatal 5-HT when co-administered with moclobemide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Long-lasting depletion of striatal dopamine by a single injection of amphetamine in iprindole-treated rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Myocardial infarction in an adolescent taking Adderall

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Methamphetamine and 3,4-methylenedioxymethamphetamine interact with central nicotinic receptors and induce their up-regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Tissue concentrations of MDMA and its metabolite MDA in three fatal cases of overdose.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Fatal combination of ecstasy and heroin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Ecstasy during loud noise exposure induces dramatic ultrastructural changes in the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Loud noise enhances nigrostriatal dopamine toxicity induced by MDMA in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

CYP2D6 deficiency, a factor in ecstasy related deaths?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Amphetamine intoxication with coagulopathy, hyperthermia, and reversible renal failure. A syndrome resembling heatstroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

A review of the mechanisms involved in the acute MDMA (ecstasy)-induced hyperthermic response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Multiple toxicity from 3,4-methylenedioxymethamphetamine ("ecstasy").

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Review article: Amphetamines and related drugs of abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Dantrolene in the treatment of MDMA-related hyperpyrexia: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Methamphetamine-induced deficits of brain monoaminergic neuronal markers: distal axotomy or neuronal plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Naltrexone attenuates amphetamine-induced locomotor sensitization in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Pharmacogenetic treatments for drug addiction: cocaine, amphetamine and methamphetamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Delayed rhabdomyolysis after ecstasy use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Acute toxic effects of 'Ecstasy' (MDMA) and related compounds: overview of pathophysiology and clinical management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Interactions between ethanol and cocaine, amphetamine, or MDMA in the rat: thermoregulatory and locomotor effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Polymorphisms in dopamine transporter (SLC6A3) are associated with stimulant effects of D-amphetamine: an exploratory pharmacogenetic study using healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Life-threatening interactions between HIV-1 protease inhibitors and the illicit drugs MDMA and gamma-hydroxybutyrate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

The bioavailability of intranasal and smoked methamphetamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Acute physiological and behavioral effects of intranasal methamphetamine in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

A functional glutathione S-transferase P1 gene polymorphism is associated with methamphetamine-induced psychosis in Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

3,4-Methylenedioxy analogues of amphetamine: defining the risks to humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Ecstasy and the dance of death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Fatal interaction between ritonavir and MDMA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy")

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

3,4-Methylenedioxymethamphetamine (ecstasy) and alcohol interactions in humans: psychomotor performance, subjective effects, and pharmacokinetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Mechanism-based inactivation of CYP2D6 by methylenedioxymethamphetamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Contribution of CYP3A4, CYP2B6, and CYP2C9 isoforms to N-demethylation of ketamine in human liver microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Interindividual variation in anxiety response to amphetamine: possible role for adenosine A2A receptor gene variants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Pathogenesis and treatment of renal dysfunction in rhabdomyolysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Contraction band necrosis in two ecstasy abusers: a latent lethal lesion associated with ecstasy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

The norepinephrine transporter inhibitor reboxetine reduces stimulant effects of MDMA ("ecstasy") in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Linkage disequilibrium and association with methamphetamine dependence/psychosis of mu-opioid receptor gene polymorphisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Peroxynitrite plays a role in methamphetamine-induced dopaminergic neurotoxicity: evidence from mice lacking neuronal nitric oxide synthase gene or overexpressing copper-zinc superoxide dismutase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Effect of diet and nutrition on the expression of cytochromes P450.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Immunohistochemical study of myoglobin and oxidative injury-related markers in the kidney of methamphetamine abusers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Histopathological studies of cardiac lesions after long term administration of methamphetamine in high dosage--Part II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

A comparison of echocardiographic findings in young adults with cardiomyopathy: with and without a history of methamphetamine abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Binge ethanol administration enhances the MDMA-induced long-term 5-HT neurotoxicity in rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Reversible dilated cardiomyopathy induced by methamphetamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Pharmacological and behavioral determinants of cocaine, methamphetamine, 3,4-methylenedioxymethamphetamine, and para-methoxyamphetamine-induced hyperthermia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

The effect of long-term repeated exposure to 3,4-methylenedioxymethamphetamine on cardiovascular and thermoregulatory changes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Methamphetamine induces neuronal apoptosis via cross-talks between endoplasmic reticulum and mitochondria-dependent death cascades

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Effects of naltrexone on the subjective response to amphetamine in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Naltrexone attenuates the subjective effects of amphetamine in patients with amphetamine dependence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Methamphetamine-enhanced embryonic oxidative DNA damage and neurodevelopmental deficits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Neurotoxicity of amphetamine derivatives is mediated by caspase pathway activation in rat cerebellar granule cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Chronic treatment with supraphysiological levels of corticosterone enhances D-MDMA-induced dopaminergic neurotoxicity in the C57BL/6J female mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

d-MDMA during vitamin E deficiency: effects on dopaminergic neurotoxicity and hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Brain concentrations of d-MDMA are increased after stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Driving under the influence of drugs in Sweden with zero concentration limits in blood for controlled substances.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Serotonergic neurotoxic metabolites of ecstasy identified in rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Selective (+)-amphetamine neurotoxicity on striatal dopamine nerve terminals in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Amphetamine induces dopamine efflux through a dopamine transporter channel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Non-alcoholic fatty liver disease in HIV-positive patients predisposes for acute-on-chronic liver failure: two cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

GHB and synthetic cathinones: clinical effects and potential consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Methamphetamine and cardiovascular pathology: a review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

The supra-additive hyperactivity caused by an amphetamine-chlordiazepoxide mixture exhibits an inverted-U dose response: negative implications for the use of a model in screening for mood stabilizers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Rhabdomyolysis and shock after intravenous amphetamine administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

The role of intracellular signaling in insulin-mediated regulation of drug metabolizing enzyme gene and protein expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Urinary pharmacokinetics of methamphetamine and its metabolite, amphetamine following controlled oral administration to humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Decreased cerebral cortical serotonin transporter binding in ecstasy users: a positron emission tomography/[(11)C]DASB and structural brain imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Dopamine-induced behavioral changes and oxidative stress in methamphetamine-induced neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Methamphetamine-induced neurotoxicity: structure activity relationships

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

The adenosine A2A receptor is associated with methamphetamine dependence/psychosis in the Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Plasma pharmacokinetics of 3,4-methylenedioxymethamphetamine after controlled oral administration to young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Amnesic syndrome and severe ataxia following the recreational use of 3,4-methylene-dioxymethamphetamine (MDMA, 'ecstasy') and other substances.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Toxicokinetics of amphetamines: metabolism and toxicokinetic data of designer drugs, amphetamine, methamphetamine, and their N-alkyl derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Methamphetamine toxicity and messengers of death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Sub-chronic nandrolone treatment modifies neurochemical and behavioral effects of amphetamine and 3,4-methylenedioxymethamphetamine (MDMA) in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Interactions between 3,4-methylenedioxymethamphetamine, methamphetamine, ketamine, and caffeine in human intestinal Caco-2 cells and in oral administration to rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

MDMA and alcohol effects, combined and alone, on objective and subjective measures of actual driving performance and psychomotor function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Transient proximal tubular renal injury following Ecstasy ingestion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Acute effects of MDMA (3,4-methylenedioxymethamphetamine) on EEG oscillations: alone and in combination with ethanol or THC (delta-9-tetrahydrocannabinol).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Self-stimulation and amphetamine: tolerance to d and l isomers and cross tolerance to cocaine and methylphenidate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Pharmacogenetics of the serotonin transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Cardiovascular effects of 3,4-methylenedioxymethamphetamine. A double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Association analysis of the DRD4 and COMT genes in methamphetamine abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Effect of methamphetamine on potassium and L-type calcium currents in rat ventricular myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

The serotonin uptake inhibitor citalopram reduces acute cardiovascular and vegetative effects of 3,4-methylenedioxymethamphetamine ('Ecstasy') in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Acute psychological effects of 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") are attenuated by the serotonin uptake inhibitor citalopram

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Psychological and physiological effects of MDMA ("Ecstasy") after pretreatment with the 5-HT(2) antagonist ketanserin in healthy humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Gender differences in the subjective effects of MDMA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Comparison of the behavioral and cardiovascular effects of intranasal and oral d-amphetamine in healthy human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Enzymatic and chemical demethylenation of (methylenedioxy)amphetamine and (methylenedioxy)methamphetamine by rat brain microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Oxidative stress contributes to methamphetamine-induced left ventricular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Dopamine transporter gene associated with diminished subjective response to amphetamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Serotonin transporter genotype and acute subjective response to amphetamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Heat stroke-induced multiple organ failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Hemodynamic and cardiac neurotransmitter-releasing effects in conscious dogs of attention- and wake-promoting agents: a comparison of d-amphetamine, atomoxetine, modafinil, and a novel quinazolinone H3 inverse agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Methamphetamine induces an increase in cell size and reorganization of myofibrils in cultured adult rat cardiomyocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Direct effects of methamphetamine on hypertrophy and microtubules in cultured adult rat ventricular myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Amphetamine Induced Increase in Tyrosine Hydroxylase Activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Inhibition of monoamine oxidase by amphetamine and related compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Cardiomyopathy due to ingestion of Adderall

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

A novel mutant variant of the CYP2D6 gene (CYP2D6*17) common in a black African population: association with diminished debrisoquine hydroxylase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Catechol O -methyltransferase val 158 -met genotype and individual variation in the brain response to amphetamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Serotonin neurotoxicity after (+/-)3,4-methylenedioxymethamphetamine (MDMA; "Ecstasy"): a controlled study in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Adverse reactions with 3,4-methylenedioxymethamphetamine (MDMA; 'ecstasy').

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Cognitive performance in (+/-) 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") users: a controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Quantitative PET studies of the serotonin transporter in MDMA users and controls using [11C]McN5652 and [11C]DASB

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Positron emission tomographic studies of brain dopamine and serotonin transporters in abstinent (+/-)3,4-methylenedioxymethamphetamine ("ecstasy") users: relationship to cognitive performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Vascular actions of MDMA involve alpha1 and alpha2-adrenoceptors in the anaesthetized rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Congenital anomalies after prenatal ecstasy exposure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA ("Ecstasy") and MDA ("Love").

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

The pharmacology of the acute hyperthermic response that follows administration of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') to rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Implications of pharmacogenetics for individualizing drug treatment and for study design

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Long-term methamphetamine administration in the vervet monkey models aspects of a human exposure: brain neurotoxicity and behavioral profiles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Methamphetamine and ethanol interactions in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Enantioselective metabolism of the designer drugs 3,4-methylenedioxymethamphetamine ('ecstasy') and 3,4-methylenedioxyethylamphetamine ('eve') isomers in rat brain and blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Rewarding effects of the optical isomers of 3,4-methylenedioxy-methylamphetamine ('Ecstasy') and 3,4-methylenedioxy-ethylamphetamine ('Eve') measured by conditioned place preference in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Neurotoxic effects of MDMA ("ecstasy") administration to neonatal rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Elevated environmental temperature and methamphetamine neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Effects of intracerebroventricular administration of 5-(glutathion-S-yl)-alpha-methyldopamine on brain dopamine, serotonin, and norepinephrine concentrations in male Sprague-Dawley rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

2,5-Bis-(glutathion-S-yl)-alpha-methyldopamine, a putative metabolite of (+/-)-3,4-methylenedioxyamphetamine, decreases brain serotonin concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Pharmacology: uncoupling the agony from ecstasy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

The role of the sympathetic nervous system and uncoupling proteins in the thermogenesis induced by 3,4-methylenedioxymethamphetamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Pathology of deaths associated with "ecstasy" and "eve" misuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Neurotoxicity of MDMA and related compounds: anatomic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

The role of metabolism in 3,4-(+)-methylenedioxyamphetamine and 3,4-(+)-methylenedioxymethamphetamine (ecstasy) toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

3,4-Methylenedioxymethamphetamine ("Ecstasy") induces apoptosis of cultured rat liver cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Role of reactive oxygen species, glutathione and NF-kappaB in apoptosis induced by 3,4-methylenedioxymethamphetamine ("Ecstasy") on hepatic stellate cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Mechanism of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy)-mediated mitochondrial dysfunction in rat liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Distribution of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) stereoisomers in a fatal poisoning

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Regulation of cytochromes P450 during inflammation and infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Cannabinoids prevent the acute hyperthermia and partially protect against the 5-HT depleting effects of MDMA ("Ecstasy") in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Reverse or inverted left ventricular apical ballooning syndrome (reverse Takotsubo cardiomyopathy) in a young woman in the setting of amphetamine use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Direct comparison of (+/-) 3,4-methylenedioxymethamphetamine ("ecstasy") disposition and metabolism in squirrel monkeys and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Blood coagulation and fibrinolysis in heat stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Progress in monoamine oxidase (MAO) research in relation to genetic engineering

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Cytotoxic effects of 3,4-methylenedioxy-N-alkylamphetamines, MDMA and its analogues, on isolated rat hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Methamphetamine users show greater than normal age-related cortical gray matter loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Methamphetamine neurotoxicity and striatal glutamate release: comparison to 3,4-methylenedioxymethamphetamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Cocaine and methamphetamine produce different patterns of subjective and cardiovascular effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Safety of intravenous methamphetamine administration during treatment with bupropion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Bupropion reduces methamphetamine-induced subjective effects and cue-induced craving.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

N-methyl-3,4-methylenedioxyamphetamine-induced hepatotoxicity in rats: oxidative stress after acute and chronic administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Haplotype association between GABAA receptor gamma2 subunit gene (GABRG2) and methamphetamine use disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Potent serotonin (5-HT)(2A) receptor antagonists completely prevent the development of hyperthermia in an animal model of the 5-HT syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Diazepam and chlormethiazole attenuate the development of hyperthermia in an animal model of the serotonin syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Genetic variant of prodynorphin gene is risk factor for methamphetamine dependence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Plasma protein binding of drugs in pregnancy and in neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Cardiovascular and sympathetic responses and reflex changes elicited by MDMA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

MDMA toxicity: no evidence for a major influence of metabolic genotype at CYP2D6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Ecstasy: pharmacodynamic and pharmacokinetic interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Ecstasy use among Hispanic and black substance users in New York City

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Spinal 5-HT2A receptors regulate cutaneous sympathetic vasomotor outflow in rabbits and rats; relevance for cutaneous vasoconstriction elicited by MDMA (3,4-methylenedioxymethamphetamine, "Ecstasy") and its reversal by clozapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Combined immunomodulating properties of 3,4-methylenedioxymethamphetamine (MDMA) and cannabis in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

The effects of gender, age, ethnicity, and liver cirrhosis on cytochrome P450 enzyme activity in human liver microsomes and inducibility in cultured human hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

MDMA (3,4-Methylenedioxymethamphetamine) or ecstasy: the neuropsychobiological implications of taking it at dances and raves

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

MDMA and temperature: a review of the thermal effects of 'Ecstasy' in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Cannabis and Ecstasy/MDMA (3,4-methylenedioxymethamphetamine): an analysis of their neuropsychobiological interactions in recreational users

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Differences in club drug use between heterosexual and lesbian/bisexual females

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Interaction of amphetamines and related compounds at the vesicular monoamine transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

The pharmacology of psilocybin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Transformation of dopamine and alpha-methyldopamine by NG108-15 cells: formation of thiol adducts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Methylenedioxymethamphetamine (ecstasy)-related hyperthermia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Acute increase of the glutamate-glutamine cycling in discrete brain areas after administration of a single dose of amphetamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

D2 dopamine receptor gene TaqI A1 and B1 restriction fragment length polymorphisms: enhanced frequencies in psychostimulant-preferring polysubstance abusers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

The effect of various environmental factors on cocaine and eph edrine toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Deaths involving serotonergic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Deaths involving MDMA and the concomitant use of pharmaceutical drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Serotonin toxicity involving MDMA (ecstasy) and moclobemide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Urinary excretion of d-amphetamine following oral doses in humans: implications for urine drug testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Chronic exposure to ethanol exacerbates MDMA-induced hyperthermia and exposes liver to severe MDMA-induced toxicity in CD1 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Synergistic toxicity of ethanol and MDMA towards primary cultured rat hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Metabolic interactions between ethanol and MDMA in primary cultured rat hepatocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Long-term effects of repeated methylamphetamine administration on monoamine neurons in the rhesus monkey brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

The effects of amfonelic acid, a dopamine uptake inhibitor, on methamphetamine-induced dopaminergic terminal degeneration and astrocytic response in rat striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Pharmacokinetic and pharmacodynamic principles of illicit drug use and treatment of illicit drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Blockade of noradrenaline transport abolishes 4-methylthioamphetamine-induced contraction of the rat aorta in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on behavioral measures of impulsivity: alone and in combination with alcohol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Phosphorylation and sequestration of serotonin transporters differentially modulated by psychostimulants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Cytochrome P450 2D6.1 and cytochrome P450 2D6.10 differ in catalytic activity for multiple substrates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Reduced (+/-)-3,4-methylenedioxymethamphetamine ("Ecstasy") metabolism with cytochrome P450 2D6 inhibitors and pharmacogenetic variants in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Ecstasy-fueled 'rave' parties become dances of death for English youths.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

MDMA polydrug users show process-specific central executive impairments coupled with impaired social and emotional judgement processes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Alteration of drug biotransformation and elimination during infection and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Cytochrome P450 regulation and drug biotransformation during inflammation and infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Regulation of drug metabolism and disposition during inflammation and infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Further evidence that amphetamines produce long-lasting dopamine neurochemical deficits by destroying dopamine nerve fibers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Hallucinogenic amphetamine selectively destroys brain serotonin nerve terminals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Methamphetamine abuse and rhabdomyolysis in the ED: a 5-year study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Effects of ethanol and 3,4-methylenedioxymethamphetamine (MDMA) alone or in combination on spontaneous and evoked overflow of dopamine, serotonin and acetylcholine in striatal slices of the rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Survival following intentional massive overdose of 'Ecstasy'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Tissue distribution of methylenedioxymethamphetamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Association of a functional polymorphism in the serotonin transporter gene with abnormal emotional processing in ecstasy users

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

The effect of polymorphism at the serotonin transporter gene on decision-making, memory and executive function in ecstasy users and controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Toxin-induced hyperthermic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Endocannabinoids and 3,4-methylenedioxymethamphetamine (MDMA) interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Fetal effects of psychoactive drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Plasma, oral fluid and sweat wipe ecstasy concentrations in controlled and real life conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Effect of drugs on the noradrenaline content of brain and peripheral tissues and its significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

The mechanisms involved in the long-lasting neuroprotective effect of fluoxetine against MDMA ('ecstasy')-induced degeneration of 5-HT nerve endings in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Methylphenidate alters vesicular monoamine transport and prevents methamphetamine-induced dopaminergic deficits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

A fatal case of myocardial damage due to misuse of the "designer drug" MDMA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

'Candyflipping': synergistic discriminative effect of LSD and MDMA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Methamphetamine and amphetamine pharmacokinetics in oral fluid and plasma after controlled oral methamphetamine administration to human volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

A bitter pill. Overview of ecstasy (MDMA, MDA) related fatalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

MDMA ('ecstasy') consumption in the context of polydrug abuse: a report on 150 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Methylenedioxymethamphetamine: a potentially neurotoxic amphetamine analogue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Demonstration and localization of neuronal degeneration in the rat forebrain following a single exposure to MDMA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Increased intensity of Ecstasy and polydrug usage in the more experienced recreational Ecstasy/MDMA users: a WWW study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Global and local morphometric differences in recently abstinent methamphetamine-dependent individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Hyperpyrexia and rhabdomyolysis after MDMA ("ecstasy") abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

3,4-Dihydroxymethamphetamine (HHMA). A major in vivo 3,4-methylenedioxymethamphetamine (MDMA) metabolite in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Contribution of cytochrome P450 2D6 to 3,4-methylenedioxymethamphetamine disposition in humans: use of paroxetine as a metabolic inhibitor probe

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Long-term methamphetamine induced changes in brain catecholamines in tolerant rhesus monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Alpha1-adrenergic receptors mediate the locomotor response to systemic administration of (+/-)-3,4-methylenedioxymethamphetamine (MDMA) in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Chronopharmacokinetics and chronopharmacodynamics of dextromethamphetamine in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Comparative metabolic capabilities and inhibitory profiles of CYP2D6.1, CYP2D6.10, and CYP2D6.17

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Metabolites of MDMA induce oxidative stress and contractile dysfunction in adult rat left ventricular myocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

The cardiovascular and cardiac actions of ecstasy and its metabolites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

The background and chemistry of MDMA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Association of brain-derived neurotrophic factor (Val66Met) genetic polymorphism with methamphetamine dependence in a Malaysian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

The reverse operation of Na(+)/Cl(-)-coupled neurotransmitter transporters--why amphetamines take two to tango.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Effects of hyperthermia on xanthine oxidase activity and glutathione levels in the perfused rat liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

A case of MAO inhibitor/MDMA interaction: agony after ecstasy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Cardiomyopathy associated with amphetamine administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Atomoxetine attenuates dextroamphetamine effects in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Recreational MDMA use in Sydney: a profile of 'Ecstacy' users and their experiences with the drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Mechanisms of MDMA (ecstasy)-induced oxidative stress, mitochondrial dysfunction, and organ damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Safety of ephedra: lessons learned

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Hypothalamic-pituitary-thyroid axis and sympathetic nervous system involvement in hyperthermia induced by 3,4-methylenedioxymethamphetamine (Ecstasy).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Carvedilol reverses hyperthermia and attenuates rhabdomyolysis induced by 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) in an animal model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Amphetamine increases blood pressure and heart rate but has no effect on motor recovery or cerebral haemodynamics in ischaemic stroke: a randomized controlled trial (ISRCTN 36285333).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Monitoring synthetic drug markets, trends, and public health

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

The effects of co-administration of 3,4-methylenedioxymethamphetamine ("ecstasy") or para-methoxyamphetamine and moclobemide at elevated ambient temperatures on striatal 5-HT, body temperature and behavior in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Differences in the central serotonergic effects of methylenedioxymethamphetamine (MDMA) in mice and rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Methamphetamine directly accelerates beating rate in cardiomyocytes by increasing Ca(2+) entry via L-type Ca(2+) channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Mechanisms of neurotransmitter release by amphetamines: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

The effects of fluoxetine on the subjective and physiological effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Pharmacological content of tablets sold as "ecstasy": results from an online testing service

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Microglial activation is a pharmacologically specific marker for the neurotoxic amphetamines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Chronic fluoxetine treatment partly attenuates the long-term anxiety and depressive symptoms induced by MDMA ('Ecstasy') in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Structural abnormalities in the brains of human subjects who use methamphetamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Screening of unsubstituted cyclic compounds as inhibitors of monoamine oxidases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Nine- or fewer repeat alleles in VNTR polymorphism of the dopamine transporter gene is a strong risk factor for prolonged methamphetamine psychosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Genetic variants of D2 but not D3 or D4 dopamine receptor gene are associated with rapid onset and poor prognosis of methamphetamine psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Pharmacological aspects of the combined use of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and gamma-hydroxybutyric acid (GHB): a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Long-term effects of prenatal stress and handling on metabolic parameters: relationship to corticosterone secretion response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Sedative and hypothermic effects of gamma-hydroxybutyrate (GHB) in rats alone and in combination with other drugs: assessment using biotelemetry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Residual social, memory and oxytocin-related changes in rats following repeated exposure to γ-hydroxybutyrate (GHB), 3,4-methylenedioxymethamphetamine (MDMA) or their combination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Caffeine promotes dopamine D1 receptor-mediated body temperature, heart rate and behavioural responses to MDMA ('ecstasy').

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Mechanisms mediating the ability of caffeine to influence MDMA ('Ecstasy')-induced hyperthermia in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

A role for adenosine A(1) receptor blockade in the ability of caffeine to promote MDMA "Ecstasy"-induced striatal dopamine release

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

3,4-methylenedioxymethamphetamine ("Ecstasy") stimulates the expression of alpha1(I) procollagen mRNA in hepatic stellate cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Cardiovascular responses elicited by the "binge" administration of methamphetamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Prevalence and magnitude of perinatal substance exposures in California

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

MDMA-induced impairment in primates: antagonism by a selective norepinephrine or serotonin, but not by a dopamine/norepinephrine transport inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Distribution and pharmacokinetics of methamphetamine in the human body: clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Effects of high amphetamine dose on mood and cerebral glucose metabolism in normal volunteers using positron emission tomography (PET).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Impact of ambient temperature on hyperthermia induced by (+/-)3,4-methylenedioxymethamphetamine in rhesus macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

DeltaPsi(m)-Dependent and -independent production of reactive oxygen species by rat brain mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Death following ingestion of MDMA (ecstasy) and moclobemide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Acute myocardial infarction associated with amphetamine use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Fatal multi-organ failure after suicidal overdose with MDMA, 'ecstasy': case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Effects of alpha-phenyl-N-tert-butyl nitrone and N-acetylcysteine on hydroxyl radical formation and dopamine depletion in the rat striatum produced by d-amphetamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Ecstasy toxicity: a comparison to methamphetamine and traumatic brain injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Calpain and caspase proteolytic markers co-localize with rat cortical neurons after exposure to methamphetamine and MDMA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Methylation pharmacogenetics: catechol O-methyltransferase, thiopurine methyltransferase, and histamine N-methyltransferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Atypical antipsychotics not recommended for control of agitation in the emergency department

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Age-dependent differences in sensitivity and sensitization to cannabinoids and 'club drugs' in male adolescent and adult rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

"Saturday night fever": ecstasy related problems in a London accident and emergency department

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Effects of hyperthermia therapy on the liver. II. Morphological observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Dextroamphetamine causes a change in regional brain activity in vivo during cognitive tasks: a functional magnetic resonance imaging study of blood oxygen level-dependent response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Drugs and the dance music scene: a survey of current drug use patterns among a sample of dance music enthusiasts in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Cardiac safety of methylphenidate versus amphetamine salts in the treatment of ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Ketamine : from medicine to misuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Long-term effects of chronic methamphetamine administration in rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Interactions of amphetamine analogs with human liver CYP2D6

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Enhanced oxidative stress and aberrant mitochondrial biogenesis in human neuroblastoma SH-SY5Y cells during methamphetamine induced apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

The hyperthermia mediated by 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) is sensitive to sex differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Loss of serotonin transporter protein after MDMA and other ring-substituted amphetamines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Deamination of amphetamines by cytochromes P450: studies on substrate specificity and regioselectivity with microsomes and purified CYP2C subfamily isozymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

The role of oxidative stress, metabolic compromise, and inflammation in neuronal injury produced by amphetamine-related drugs of abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Amphetamine toxicities: classical and emerging mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Implications of mechanism-based inhibition of CYP2D6 for the pharmacokinetics and toxicity of MDMA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

The association of methamphetamine use and cardiomyopathy in young patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Excitotoxic mechanisms and the role of astrocytic glutamate transporters in traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Discriminative stimulus properties of amphetamine and structurally related phenalkylamines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Co-administration of THC and MDMA ('ecstasy') synergistically disrupts memory in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Indolealkylamines: biotransformations and potential drug-drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Effects of L-cysteine on the oxidation chemistry of dopamine: new reaction pathways of potential relevance to idiopathic Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Synthesis and neurotoxicological evaluation of putative metabolites of the serotonergic neurotoxin 2-(methylamino)-1-[3,4-(methylenedioxy)phenyl] propane [(methylenedioxy)methamphetamine]

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Methamphetamine-induced cell death: selective vulnerability in neuronal subpopulations of the striatum in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Monoamine Oxidase-B Mediates Ecstasy-Induced Neurotoxic Effects to Adolescent Rat Brain Mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

Oxidation Process of Adrenaline in Freshly Isolated Rat Cardiomyocytes: Formation of Adrenochrome, Quinoproteins, and GSH Adduct

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

FATAL AMPHETAMINE POISONING

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

An unusual pattern of ST-segment elevation

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

The complications of 'ecstasy' (MDMA)

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

Chemical analysis of ecstasy pills

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

In vivo formation of aromatic hydroxylated metabolites of 3,4-(methylenedioxy)methamphetamine in the rat: Identification by ion trap tandem mass spectrometric (MS/MS and MS/MS/MS) techniques

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

Fluoxetine pretreatment effects pharmacokinetics of 3,4-methylenedioxymethamphetamine (MDMA, ECSTASY) in rat

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

Fatal poisoning by MDMA (ecstasy) and MDEA: a case report

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

Behavioural and neurochemical effects of combined MDMA and THC administration in mice

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

Acute myocardial infarction in a teenager due to Adderall XR

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

1 reference

7 January 2021

Inhibition of monoamine oxidase by d-methamphetamine

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

In vitro and in vivo neurochemical effects of methylenedioxymethamphetamine on striatal monoaminergic systems in the rat brain

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

The demethylenation of methylenedioxymethamphetamine ("ecstasy") by debrisoquine hydroxylase (CYP2D6)

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

Early pharmacokinetics and clinical effects of oral D-amphetamine in normal subjects

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

Release of serotonin induced by 3,4-methylenedioxymethamphetamine (MDMA) and other substituted amphetamines in cultured fetal raphe neurons: further evidence for calcium-independent mechanisms of release

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

A comparison of the neurotoxic potential of methylenedioxyamphetamine (MDA) and its N-methylated and N-ethylated derivatives

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

Fluorescence histochemistry indicates damage of striatal dopamine nerve terminals in rats after multiple doses of methamphetamine

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

Clinical effects of methamphetamine vapor inhalation

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

Motility of mice after amphetamine: effects of strain, aggregation and illumination

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

Effects of 3,4-methylenedioxymethamphetamine on autonomic thermoregulatory responses of the rat

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

Cloning, expression and structure of catechol-O-methyltransferase.

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

Depletion of total non-protein sulphydryl groups in mouse tissues after administration of d-amphetamine

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

The unique histology of methamphetamine cardiomyopathy: a case report

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

Identification of the human cytochromes P450 involved in the oxidative metabolism of "Ecstasy"-related designer drugs

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

Induction of CYP2D6 in pregnancy

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

Age and cytochrome P450-linked drug metabolism in humans: an analysis of 226 subjects with equal histopathologic conditions

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

Rapid and transient inhibition of mitochondrial function following methamphetamine or 3,4-methylenedioxymethamphetamine administration

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

Sympatho-adrenal involvement in methamphetamine-induced hyperthermia through skeletal muscle hypermetabolism

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

Involvement of the serotonin transporter in the formation of hydroxyl radicals induced by 3,4-methylenedioxymethamphetamine

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

Systemic administration of d-amphetamine induces long-lasting oxidative stress in the rat striatum

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

Amphetamine induces hydroxyl radical formation in the striatum of rats

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

Fatal MDMA intoxication

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

Healthy nightclubs and recreational substance use. From a harm minimisation to a healthy settings approach.

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

Toxicokinetics and analytical toxicology of amphetamine-derived designer drugs ('Ecstasy')

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

Testing for drugs of abuse in saliva and sweat

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

The toxicological potential of khat

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

Adam (MDMA) and Eve (MDEA) misuse: an immunohistochemical study on three fatal cases

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

Quantification of amphetamine plasma concentrations by gas chromatography coupled to mass spectrometry

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

Inhibitory metabolite complex formation of methylenedioxymethamphetamine with rat and human cytochrome P450. Particular involvement of CYP 2D

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

Long-term cardiovascular effects of mixed amphetamine salts extended release in adults with ADHD.

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

In vivo and in vitro metabolism of 3,4-(methylenedioxy)methamphetamine in the rat: identification of metabolites using an ion trap detector

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

Identification of metabolites of 3,4-(methylenedioxy)methamphetamine in human urine

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

Hydroxyl radical mediated demethylenation of (methylenedioxy)phenyl compounds

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

d-Amphetamine Interaction with Glutathione in Freshly Isolated Rat Hepatocytes

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

Glutathione and N-acetylcysteine conjugates of alpha-methyldopamine produce serotonergic neurotoxicity: possible role in methylenedioxyamphetamine-mediated neurotoxicity

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

Ecstasy-induced toxicity in rat liver

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

Striatal dopamine nerve terminal markers in human, chronic methamphetamine users

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

Malignant hyperthermia

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

Carrier-mediated release of serotonin by 3,4-methylenedioxymethamphetamine: implications for serotonin-dopamine interactions.

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

Conjugates of catecholamines with cysteine and GSH in Parkinson's disease: possible mechanisms of formation involving reactive oxygen species.

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

Involvement of CYP2D6 in the in vitro metabolism of amphetamine, two N-alkylamphetamines and their 4-methoxylated derivatives

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

Route of administration and adverse effects of amphetamine use among young adults in Syndney, Australia

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

Analysis of methamphetamine in hair, nail, sweat, and saliva by mass fragmentography

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

Analysis of 3,4-methylenedioxymethamphetamine (MDMA) and its metabolites in plasma and urine by HPLC-DAD and GC-MS

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

What do diet-induced changes in phase I and II enzymes tell us about prevention from exposure to heterocyclic amines?

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

Prolonged elevation of serum creatine kinase (CK) without renal failure after ingestion of ecstasy

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

Amphetamines induce apoptosis and regulation of bcl-x splice variants in neocortical neurons

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

Amphetamine induces apoptosis of medium spiny striatal projection neurons via the mitochondria-dependent pathway

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

"Ecstasy" and sudden cardiac death

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

Cocaine alters body temperature and behavioral thermoregulatory responses.

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

Clinical effects of daily methamphetamine administration

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

Hepatotoxicity and accelerated fibrosis following 3,4-methylenedioxymetamphetamine ("ecstasy") usage

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

On the metabolism and the toxicological analysis of methylenedioxyphenylalkylamine designer drugs by gas chromatography-mass spectrometry

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders.

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

Elucidation of the genetic basis of the common 'intermediate metabolizer' phenotype for drug oxidation by CYP2D6

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

Fatal amphetamine-associated cardiotoxicity and its medicolegal implications

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

3,4-Methylenedioxymethamphetamine (Ecstasy) increases the sensitivity of the contractile apparatus to calcium ions in both malignant hyperthermia-susceptible and normal skeletal muscle fibres

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

3,4-Methylenedioxymethamphetamine (ecstasy)-induced hepatotoxicity: effect on cytosolic calcium signals in isolated hepatocytes

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

Interaction between ethanol and dextroamphetamine: effects on psychomotor performance

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

Sympathomimetic actions of methylenedioxymethamphetamine in rat and rabbit isolated cardiovascular tissues

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

Roles of norepinephrine, free Fatty acids, thyroid status, and skeletal muscle uncoupling protein 3 expression in sympathomimetic-induced thermogenesis

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

Nothing ever changes...

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

The pharmacology and toxicology of polyphenolic-glutathione conjugates

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

Can drugs be used to enhance the psychotherapeutic process?

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

Ecstasy, 3–4 Methylenedioxymethamphetamine (MDMA), a Fatality Associated with Coagulopathy and Hyperthermia

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

A fatal trip with ecstasy: a case of 3,4-methylenedioxymethamphetamine/3,4- methylenedioxyamphetamine toxicity

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

Creatine kinase isoform changes following Ecstasy overdose.

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

Synthesis and Cyclic Voltammetry Studies of 3,4-Methylenedioxymethamphetamine (MDMA) Human Metabolites

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity.

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

Reorganization of ascending 5-HT axon projections in animals previously exposed to the recreational drug (+/-)3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

Role of dopamine transporter in methamphetamine-induced neurotoxicity: evidence from mice lacking the transporter.

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

Small changes in ambient temperature cause large changes in 3,4-methylenedioxymethamphetamine (MDMA)-induced serotonin neurotoxicity and core body temperature in the rat.

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

Amphetamine distorts stimulation-dependent dopamine overflow: effects on D2 autoreceptors, transporters, and synaptic vesicle stores.

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

Cutaneous vasoconstriction contributes to hyperthermia induced by 3,4-methylenedioxymethamphetamine (ecstasy) in conscious rabbits.

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

Selective blockade of mGlu5 metabotropic glutamate receptors is protective against methamphetamine neurotoxicity.

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

Clozapine reverses hyperthermia and sympathetically mediated cutaneous vasoconstriction induced by 3,4-methylenedioxymethamphetamine (ecstasy) in rabbits and rats.

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

Acute heat stroke deaths

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

Hepatocellular damage following amphetamine intoxication

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021

Survival after massive ecstasy overdose

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0815-5

7 January 2021